Loading...

Why are some drugs scheduled under the Controlled Substances Act (CSA)? How does a company hoping to test a CSA-scheduled drug to determine its potential medical value get access to it? What processes do players in the drug manufacturing and distribution chain need to follow if an approved drug falls under CSA classification? How do state controlled substance requirements differ from those of the federal government? The pharmaceutical industry is increasingly facing these kinds of questions regarding drugs subject to dual FDA and Drug Enforcement Administration (DEA) jurisdiction. Our panel of experts on both FDA and DEA law will provide an overview of the CSA, explain the interaction between the FDA and DEA regarding drugs subject to NDA approval, and discuss DEA supply chain requirements for approved drugs, including opioids. We will also discuss issues surrounding cannabis-related medical research.  

Speakers:

Larry K. Houck, Director, Hyman, Phelps & McNamara, PC
Lynn W. Mehler, Partner, Hogan Lovells US LLP
Lee Rosebush, Partner, BakerHostetler

Registration

Webinar

$99
  • +$100 for non-members
  • Includes opportunity to ask questions

Webinar & Recording

$149
  • +$100 for non-members
  • Recording provides ongoing access

An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.

Please perform the Adobe Connect Diagnostic Test to test your computer’s compatibility prior to the webinar. You may also call Adobe at 800-422-3623 for technical support.

Your organization may have strict IT policies that impede your ability to participate in the webinar. If you believe that may be the case, please perform the diagnostic test prior to purchasing a registration.

Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate computers, each will be required to purchase access.

2018-05-21T10:25:54+00:00